Organ Preservation for Cancer of the Larynx: Current Indications and Future Directions

Seminars in Radiation Oncology

Volumn 14, Issue 2, 2004, Pages 167-177

  Gilbert, Jill ^a   Forastiere, Arlene A ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ACUTE TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG RESPONSE; DRUG TOXICITY; HUMAN; LARYNGECTOMY; LARYNX CANCER; METASTASIS; MUCOSA; MUCOSA TOXICITY; ORGAN PRESERVATION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SKIN TOXICITY; STANDARD; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 2342570395     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semradonc.2003.12.003     Document Type: Article

References (43)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Athanasiadis I, Taylor S, Vokes EE, et al: Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Cancer 79:588-594, 1997
3. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55:1123-1128, 1985
4. Toohill RJ, Anderson T, Byhardt RW, et al: Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Arch Otolaryngol Head Neck Surg 113:758-761, 1987
5. Pfister D, Strong E, Harrison L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 9:850-859, 1991
6. Demard F, Chauvel P, Santini J, et al: Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Cancer 12:225-231, 1990
7. Clayman G, Weber R, Guillamondegui O, et al: Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg 121:219-223, 1995
8. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
9. Lefebvre J-L, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial. J Natl Cancer Inst 88:890-899, 1996
10. Spaulding M.B, Fischer SG, Wolf GT, et al: Cooperative Laryngeal Cancer Study Group: Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599, 1994
11. Bradford C, Wolf G, Carey T, et al: Predictive markers for response to chemotherapy, organ preservation and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg 121:534-538, 1999
12. Hillman RE, Walsh MJ, Wolf GT, et alFunctional outcomes following treatment for advanced laryngeal cancer. Part I - Voice preservation in advanced laryngeal cancer. Part II - Laryngectomy rehabilitation. The sate of the art in the VA system. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol 172(suppl):1-27, 1998
13. Mendenhall WM: T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 8:262-269, 1998
14. Mendenhall WM, Parsons JT, Mancuso AA, et al: Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 15:2394-2402, 1997
15. Mendenhall WM, Parsons JT, Mancuso AA, et al: Radiotherapy for squamous cell carcinoma of the supraglottic larynx: An alternative to surgery. Head Neck 18:24-35, 1996
16. Parsons JT, Mendenhall WM, Stringer SP, et al: T4 laryngeal carcinoma: Radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 49:549-552, 1998
17. O'Sullivan B, Mackillop W, Gilbert R, et al: Controversies in the management of laryngeal cancer: Results of an international survey of patterns of care. Radiother Oncol 31:23-32, 1994
18. Harwood AR, Hawkins NV, Beale FA, et al: Management of advanced glottic cancer. A 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys 5:899-904, 1979
19. Harwood AR, Beale FA, Cummings BJ, et al: T4N0M0 glottic cancer: An analysis of dose-time volume factor. Int J Radiat Oncol Biol Phys 7:1507-1512, 1981
20. Harwood AR, Hill RP: Supraglottic laryngeal carcinoma. Int J Radiat Oncol Biol Phys 9:1759-1769, 1983
21. Castelijns JA, van den Brekel MW, Tobi H, Smit EM, et al: Laryngeal carcinoma after radiation therapy: Correlation of abnormal MR imaging signal patterns in laryngeal cartilage with the risk of recurrence. Radiology 198: 151-155, 1996
22. Castelijns JA, Golding RP, van Schaik C, et al: MR findings of cartilage invasion by laryngeal cancer: Value in predicting outcome of radiation therapy. Radiology 174: 669-773, 1990
23. Forastiere AA, Goepfert H, Maor M, et al. A prospective comparison of three non-surgical organ preservation regimens for locally advanced cancer of the larynx. N Engl J Med 349:2091-2098, 2003
24. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent lowdose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
25. Wendt TG, Gerhard G, Grabenbauer CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
26. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
27. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999
28. Adelstein DJ, Lavertu P, Saxton JP, et al: Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88:876-883, 2000
29. Eschwege F, Sancho-Garnier H, Gerard JP, et al: Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: Experience of the European Organization for Research and Treatment of Cancer. NCI Monogr 6:275-278, 1988
30. Goodwin WJ Jr: Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110:1-18, 2000
31. Sassler AM, Esclamado RM, Wolf GT: Surgery after organ preservation therapy. Arch Otolaryngol Head Neck Surg 121:162-165, 1995
32. Lavertu P, Bonafede JP, Adelstein DJ, et al: Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124: 401-406, 1998
33. Weber RS, Berkey BA, Forastiere AA, et al: Outcome of salvage total laryngectomy following organ preservation therapy; The Radiation Therapy Oncology Group Trial 91-11. Arch Otolaryngol Head Neck Surg 129:44-49, 2003
34. Bataini P, Brugere J, Bernier J, et al: Results of a radical radiotherapeutic treatment of carcinoma of the pyriform sinus: Experience of the Instit Curie. Int J Radiat Oncol Biol Phys 8:1277-1286, 1982
35. Fletcher G, Jesse R, Lindberg R, et al: The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx. Am J Roentgenol Radium Ther Nuclear Med 108:19-26, 1970
36. Isaacs J, Mancuso A, Mendenhall W, et al: Deep spread patterns on CT staging of T2-4 squamous cell laryngeal carcinoma. Otolaryngol Head Neck Surg 99:455-464, 1988
37. Pameijer F, Mancuso A, Mendenhall W, et al: Can pre-treatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 37:1011-1021, 1997
38. Wang C, Montgomery W: Deciding on optimal management of supraglottic carcinoma. Oncology (Huntingt) 5:41-46, 1991
39. Fu KK, Pajak TH, Troti A, et al: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
40. Samant S, Robbins KT, Kumar P, et al: Bone or cartilage invasion by advanced head and neck cancer: Intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg 127:1451-1456, 2001
41. Forastiere AA, Shank D, Neuberg D, et al: Final report of a phase II evaluation of paclitaxel in advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group Trial (PA 390). Cancer 82:2270-2274, 1998
42. Gilbert J, Forastiere AA: Organ preservation trials for laryngeal cancer. Otolaryngol Clin North Am 35:1035-1004, 2002
43. Murphy BA, Smith K, Dowling E, et al. Baseline swallowing function for patients treated on E2399: A phase II trial of function preservation with induction paclitaxel/carboplatin followed by radiation plus weekly paclitaxel. Proceedings American Society of Clincial Oncology, Chicago, IL, May 31-June 3, 2003, abstract 2005, 2003